Neurology News
Deep Learning in neuroimaging for neurodegenerative diseases: State-of-the art, Challenges, and Opportunities
20 Nov 2025
A new article explores how deep learning (DL) is transforming neuroimaging for the early detection and monitoring of neurodegenerative diseases (NDDs). While DL models have shown impressive diagnostic accuracy, their clinical use remains limited by real-world variability across scanners, sites, and patient demographics.
Three neuroinfections and vaccinations
19 Nov 2025
Historian Peter J. Koehler revisits the remarkable medical journey behind three devastating infections — diphtheria, tetanus, and poliomyelitis — and the international efforts that led to their control through vaccination.
Journal of the Neurological Sciences issue 478 now available
11 Nov 2025
Vol. 478, November 2025 now available
In Memoriam Professor Michel Dumas, MD (1934–2025)
10 Nov 2025
We are deeply saddened by the passing of Professor Michel Dumas on November 8, 2025, in Limoges, France.
In Memoriam Professor Mark Hallett, MD (1943–2025)
5 Nov 2025
World Neurology: September-October issue now available online
4 Nov 2025
This issue provides the results of the election at October's Council of Delegates, which was held at the World Congress of Neurology (WCN) in Seoul, South Korea.
PNS Announces 2026 Call for Training Grant Applications — Deadline 5 January
24 Oct 2025
The PNS Laura Feltri Training Grants Program offers funding to junior investigators to develop a 2-year project under a PNS Member mentor. New in 2026, PNS will offer up to three 2-year training grants.
Prof. John Hardy Calls for a New Era of Precision and Possibility in Alzheimer’s Treatment
14 Oct 2025
At the World Congress of Neurology, Prof. Sir John Hardy (UCL, London) highlighted how decades of genetic and molecular research are driving real progress in Alzheimer’s care, with advances in amyloid therapies, microglial biology, and biomarkers paving the way for more precise diagnosis and treatment.
Prof. Sean Pittock Outlines a Bold New Era for Autoimmune Neurology — From Discovery to Targeted Immune Reset
14 Oct 2025
At the World Congress of Neurology, Prof. Sean Pittock (Mayo Clinic, USA) outlined new approaches that could accelerate lasting remission in rare autoimmune neurological diseases, including targeted CAR-T therapies, immune “reset” treatments, and innovative trial designs — marking a shift toward restoring immune balance and long-term recovery.
Web design by Tribal Systems